GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (BSP:I1LM34) » Definitions » EV-to-EBIT

Illumina (BSP:I1LM34) EV-to-EBIT : -20.26 (As of Apr. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Illumina EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Illumina's Enterprise Value is R$104,160 Mil. Illumina's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was R$-5,140 Mil. Therefore, Illumina's EV-to-EBIT for today is -20.26.

The historical rank and industry rank for Illumina's EV-to-EBIT or its related term are showing as below:

BSP:I1LM34' s EV-to-EBIT Range Over the Past 10 Years
Min: -23.07   Med: 45.92   Max: 758.23
Current: -19.98

During the past 13 years, the highest EV-to-EBIT of Illumina was 758.23. The lowest was -23.07. And the median was 45.92.

BSP:I1LM34's EV-to-EBIT is ranked worse than
100% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.2 vs BSP:I1LM34: -19.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Illumina's Enterprise Value for the quarter that ended in Dec. 2023 was R$116,400 Mil. Illumina's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was R$-5,140 Mil. Illumina's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.42%.


Illumina EV-to-EBIT Historical Data

The historical data trend for Illumina's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina EV-to-EBIT Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.37 57.96 64.48 -7.76 -22.45

Illumina Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.76 -8.48 -7.87 -22.04 -22.45

Competitive Comparison of Illumina's EV-to-EBIT

For the Diagnostics & Research subindustry, Illumina's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Illumina's EV-to-EBIT falls into.



Illumina EV-to-EBIT Calculation

Illumina's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=104160.370/-5140.156
=-20.26

Illumina's current Enterprise Value is R$104,160 Mil.
Illumina's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-5,140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Illumina  (BSP:I1LM34) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Illumina's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-5140.156/116400.109
=-4.42 %

Illumina's Enterprise Value for the quarter that ended in Dec. 2023 was R$116,400 Mil.
Illumina's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-5,140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Illumina EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Illumina's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina (BSP:I1LM34) Business Description

Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (BSP:I1LM34) Headlines

No Headlines